Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7130
-0.0291 (-3.92%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $89.94 million as of April 24, 2025. Its market cap has decreased by -73.37% in one year.
Market Cap
89.94M
Enterprise Value
-9.47M
1-Year Change
-73.37%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $89.94M, a decrease of -23.15%. That is a compound annual growth rate of -6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 93.61M | -55.62% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.29B |
| UnitedHealth Group | 389.73B |
| Johnson & Johnson | 382.05B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 228.58B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |